| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000002159 |
| Receipt No. | R000002638 |
| Official scientific title of the study | Evaluation of index for the diagnosis of asthma |
| Date of disclosure of the study information | 2009/07/03 |
| Last modified on | 2017/06/08 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Evaluation of index for the diagnosis of asthma | |
| Title of the study (Brief title) | Evaluation of index for the diagnosis of asthma | |
| Region |
|
|
| Condition | |||
| Condition | bronchial asthma | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate the diagnostic indices of spirometry, eNO (exhaled nitric oxide), several serum biomarkers, and IPAG Adult Asthma Questionnaire for patients with suspected asthma. |
| Basic objectives2 | Others |
| Basic objectives -Others | Utility of diagnostic indices |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The following parameter of each index for the diagnosis of asthma;
1) Sensitivity(%) and Specificity(%) 2) PPV(Positive Predictive Value:%), NPV(Negative Predictive Value:%) 3) ROC curve (Receiver-Operator Characteristic curve) 4) Area under the ROC curve |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Patient who has never been diagnosed as asthma
2) Patient who had either of cough, wheezing, breathing difficulties, or sputum for the past three weeks or more 3) Man and woman of 20 years old or more 4) Patient who signs the letter of consent |
|||
| Key exclusion criteria | 1) Patient who used anti-inflammatory drugs (oral/inhaled/nasal steroid, leukotriene receptor antagonist, chemical mediator release inhibitor, Th2 cytokine inhibitor, or slow-release theophylline) within the past four weeks
2) Patient who was affected with respiratory tract infection within the past three weeks 3) Patient with a history of asthma 4) Patient with breast abnormality detected by a chest X-ray 5) Patient who occurs with the following pulmonary diseases: bronchiectasis, primary pulmonary cancer, connective tissue disease, pulmonary hypertension, and/or cystic disease of the lungs 6) Patient who smoked within the past year |
|||
| Target sample size | 125 | |||
| Research contact person | |
| Name of lead principal investigator | Hironori Sagara |
| Organization | Dokkyo Medical University Koshigaya Hospital |
| Division name | Department of Respiratory Medicine |
| Address | 2-1-50 Minamikoshigaya, Koshigaya, Saitama 343-8555, Japan |
| TEL | 06-4706-3315 |
| arai@mcp.co.jp | |
| Public contact | |
| Name of contact person | Kazuo Hirono |
| Organization | MC&P Co., Ltd. |
| Division name | Medical Sciences Marketing Division |
| Address | 2-2-2 Nakanoshima, Kita-ku, Osaka, Japan |
| TEL | 06-4716-3315 |
| Homepage URL | |
| IAA@mcp.co.jp | |
| Sponsor | |
| Institute | Dokkyo Medical University Koshigaya Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Allergy Foundation |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | cross-sectional study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002638 |